Navigation Links
Study Found That Long Term Use of Advair Diskus(R) 250/50 Did Not Adversely Affect Bone Loss in Patients with COPD
Date:10/29/2008

United States. COPD is a progressive, life-threatening lung disease that includes chronic bronchitis and emphysema. It is characterized by airflow obstruction, a limitation in lung function that makes it difficult to breathe. Many patients have components of both chronic bronchitis and emphysema. Symptoms of COPD include chronic cough, chest tightness, shortness of breath, an increased effort to breathe and increased mucus production. Typically, patients with COPD develop shortness of breath during exertion, which continues and gradually worsens. Most patients also develop a productive, chronic cough. Over time, many patients suffer from shortness of breath so severe that it interferes with their most basic daily activities including sleeping, talking, and even dressing. The gradual loss of lung function, coupled with other symptoms and exacerbations, often lead to hospitalization and can be disabling and life-threatening.

GlaxoSmithKline - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer.

Cautionary statement regarding forward-looking statements

Under the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, GSK cautions investors that any forward-looking statements or projections made by GSK, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Factors that may affect GSK' s operations are described under 'Risk Factors' in the 'Business Review' in the company' s Annual Report on Form 20-F for 2007.

Registered in England & Wales:

No. 3888792

Registered Office:

980 Great West Road

Brentford, Middlesex

TW8 9GS


'/>"/>
SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Recent Study Demonstrated VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Improvements in Behavior, Inattention, and Math Test Scores from 1.5 Hours up to 13 Hours following Administration in Children with ADHD
2. Grapes May Aid a Bunch of Heart Risk Factors, U-M Animal Study Finds
3. NCI Funded Clinical Trial to Study Treatment of Breast Cancer Using Cryoablation
4. Nuvo Research presents positive Phase III study results for Pennsaid at leading rheumatology conference
5. Study Results Show Epratuzumab Provided Clinically Meaningful Reduced Disease Activity in Patients With Lupus
6. Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Next Generation Oxazolidinone at 2008 ICAAC/IDSA Joint Meeting
7. Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults
8. New Study Demonstrated ACTEMRA(R) (tocilizumab) Inhibited Progression of Joint Damage in Rheumatoid Arthritis Patients
9. ULURU Inc. Announces the Commencement of First Clinical Study Using Altrazeal(TM) Silver
10. Clinical Update - Debio 9902 SR (ZT-1) for Alzheimer Patients Debiopharm Starts Tablet Formulations Bridging Study under IND
11. Life Recovery Systems Receives NIH Grant to Study Expanded Use of Its ThermoSuit System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... 2, 2015 Pharma Major Lupin Limited ... "Biocom" in Russia subject to certain ... pharmaceutical market which recorded RUB 765 billion in sales, placing ... the world in 2014 (IMS Health). For over a decade, ... continue with this trend, projecting Russia ...
(Date:7/2/2015)... CAMBRIDGE, Mass. , and DURHAM, N.C. ... Sciences , Inc. today announced its acquisition of assets ... Inc. (NYSE: PFE ) that had previously been ... Inc.  XRPro Sciences also acquired all of Pfizer,s rights ... re-launching the Icagen brand and will provide comprehensive services ...
(Date:7/2/2015)... 2015 Research ... addition of the "2015 New Frontiers ... Emerging Technologies, Competitive Landscape" report to ... in Clinical Chemistry and Immunodiagnostics: Global Challenges, ... seven-country strategic analysis of major business opportunities ...
Breaking Medicine Technology:Lupin Acquires Biocom in Russia 2Lupin Acquires Biocom in Russia 3Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 2Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 3Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 4New Frontiers in 2015 Global Clinical Chemistry and Immunodiagnostics Market: Challenges, Emerging Technologies, Competitive Landscape 2
... (OTC: HEWA) a leading VIPPS accredited retail mail-order pharmacy, ... ended September 30, 2011. In the ... increased $1,567,764 to $2,783,240, up 129% compared to the ... strength in its prescription business.  Prescriptions filled increased from ...
... Nov. 17, 2011 Cohera Medical, a rapidly growing ... selling its lead product, TissuGlu® Surgical Adhesive, to hospitals ... regional launch will document and highlight the advantages of ... expansion throughout Germany and to additional European markets in ...
Cached Medicine Technology:HealthWarehouse.com Reports 129% Quarter-Over-Quarter Revenue Growth in the Third Quarter 2011 2Cohera Medical Commercializes TissuGlu® Surgical Adhesive in Germany 2Cohera Medical Commercializes TissuGlu® Surgical Adhesive in Germany 3
(Date:7/3/2015)... Red Deer, Alberta (PRWEB) , ... July 03, 2015 , ... ... Camp host their 24-Hour Train-a-Thon where they provide members of the Red Deer community ... This year’s full day of fitness training, games, food, events and entertainment raised thousands ...
(Date:7/2/2015)... ... ... sweetFrog Enterprises, LLC. is pleased to announce the opening of its newest location ... The premium frozen yogurt chain was listed as #22 on the Inc. 500 list ... New Albany, MS 38652, will have a grand opening event on July 4, 2015 ...
(Date:7/2/2015)... ... ... sweetFrog Enterprises, LLC. is pleased to announce the opening of its newest ... the Lone Star State. The premium frozen yogurt chain was listed as #22 on ... opened July 1 at Duke’s Travel Plaza, is located at:, 30176 Hwy 64, Suite ...
(Date:7/2/2015)... ... 02, 2015 , ... The American Association of Poison Control ... Overdose Stat (S.O.S.) Act of 2015 on June 23, 2015. Together with the ... decrease drug overdose – especially of heroin and opioid medication – by expanding ...
(Date:7/2/2015)... ... July 02, 2015 , ... Many Fourth of July celebrations ... why Amica Insurance is sharing some tips to promote the proper use ... people go to the emergency room daily with fireworks-related injuries in the month surrounding ...
Breaking Medicine News(10 mins):Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 2Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 3Health News:sweetfrog Opens First Location in Mississippi 2Health News:sweetFrog Expands Texas Footprint with Location in Canton 2Health News:AAPCC Supports the Stop Overdose Stat Act of 2015 2Health News:AAPCC Supports the Stop Overdose Stat Act of 2015 3Health News:6 Fireworks Safety Tips from Amica Insurance 2
... marital status can factor into the overall survival of ... most significant factor impacting overall survival, according to a ... Thoracic Oncology, sponsored by ASTRO, ASCO, IASLC and the ... in 2008 approximately 215,020 new cases of lung cancer ...
... small tissue samples from patients with lung cancer and ... is now being utilized to better tailor the chemotherapy ... cell lung cancer, according to a study presented at ... by ASTRO, ASCO, IASLC and the University of Chicago., ...
... targeted therapies called monoclonal antibodies showed no safety ... non-small cell lung cancer according to a study ... Thoracic Oncology, sponsored by ASTRO, ASCO, IASLC and ... and chemotherapy has been shown to increase the ...
... UPTON, NY A new study at the ... suggests that vigabatrin (a.k.a. gamma vinyl-GABA, or GVG) ... associate methamphetamine with a particular environment. Specifically, animals ... in a location where they had previously been ...
... one milliard of a metre in size are widely ... There are also significant amounts of nanoparticles in exhaust ... health effects, because only a very small portion of ... safety risks. Nanoparticles have even been dubbed the asbestos ...
... Plans, Including Medicare Advantage & Managed Medicaid, Bring,The ... BRAUNFELS, Texas, Nov. 13 In a move,expanding ... today,announced agreements with 17 insurance companies that will ... obtain power mobility equipment,from The SCOOTER Store when ...
Cached Medicine News:Health News:Chemotherapy plus targeted therapies shows improved survival in advance-stage lung cancer patients 2Health News:Hope for treating relapse to methamphetamine abuse 2Health News:Hope for treating relapse to methamphetamine abuse 3Health News:Nanoparticles trigger cell death? 2Health News:The SCOOTER Store Expands Power Mobility Products, Services to 7 Million Health Plan Members 2
... The eNclose Anastomosis ... specifically to obviate the ... of the aorta. The ... the surgeon with a ...
12mm Blades, Maximum Spread 18mm, Spring Action, Wire - Pediatric; in stainless steel...
15mm Open Blades, Thumb Screw Control; in Titanium....
15mm Open Blades, 28mm Maximum Spread; Available in small(S) and large (L), in stainless steel....
Medicine Products: